Difference between revisions of "Aortic valve repair or replacement"
Zining Chen (talk | contribs) (Completed general description and infobox) |
Zining Chen (talk | contribs) (Patient evaluation table) |
||
| Line 56: | Line 56: | ||
|- | |- | ||
|Neurologic | |Neurologic | ||
| | | -Syncope history (critical AS) | ||
-Carotid disease (stroke risk) | |||
|- | |- | ||
|Cardiovascular | |Cardiovascular | ||
| | | -AVA, mean gradient, velocity (severity) | ||
-LVEF, LVH vs LV dilation (pressure or volume overload) | |||
-Diastolic dysfunction (preload sensitivity) | |||
-pulmonary HTN (RV risk post bypass) | |||
-CAD (concomitant CABG) | |||
-Rhythm (atrial fibrillation) | |||
|- | |- | ||
|Pulmonary | |Pulmonary | ||
| | | -Restrictive lung physiology (HF/sternotomy) | ||
-COPD (prolonged vent weaning) | |||
|- | |- | ||
|Gastrointestinal | |Gastrointestinal | ||
| | | -Dysphagia, esophageal/GI tract surgeries (TEE) | ||
|- | |- | ||
|Hematologic | |Hematologic | ||
| | | -Anticoagulation use, blood products available | ||
|- | |- | ||
|Renal | |Renal | ||
| | | -Baseline Cr, kidney disease (CPB AKI risk) | ||
|- | |- | ||
|Endocrine | |Endocrine | ||
| | | -DM | ||
|- | |- | ||
|Other | |Other | ||
| | | -Endocarditis (longer CPB) | ||
|} | |} | ||
| Line 146: | Line 157: | ||
== References == | == References == | ||
[[Category:Surgical procedures]] | [[Category:Surgical procedures]] | ||
Revision as of 08:15, 17 February 2026
| Anesthesia type |
General |
|---|---|
| Airway |
ETT |
| Lines and access |
PIV, Arterial line, Central line, +/- PA catheter |
| Monitors |
Standard ASA, arterial line BP, CVP +/- PAP, TEE, NIRS |
| Primary anesthetic considerations | |
| Preoperative |
-Severity of lesion (AS vs AR) -Symptoms (syncope, angina, dyspnea) -LV function and size (hypertrophy) -Coronary disease (concomitant CABG) -Pulmonary HTN -Rhythm (atrial fibrillation) |
| Intraoperative |
-Hemodynamic goals (AS vs AR) -Full heparinization before CPB -Myocardial protection and de-airing -Conduction disturbance after valve replacement -Weaning from CPB: LV/RV function, valve seating, gradients |
| Postoperative |
-Vasoplegia -Low cardiac output syndrome -Conduction abnormalities -Bleeding -Early vs delayed extubation |
| Article quality | |
| Editor rating | |
| User likes | 0 |
Aortic valve repair or replacement is performed for aortic stenosis (AS), aortic regurgitation (AR), or mixed disease. It is performed with sternotomy under cardiopulmonary bypass (CPB). Surgical aortic valve replacement (SAVR) involves excision of the native valve and implantation of a mechanical or bioprosthetic prosthesis.
Indications:
- Symptomatic severe AS
- Severe AR with LV dilation or dysfunction
- Endocarditis with structural destruction
- Concomitant CABG requirement
- Root/ascending aortic pathology
Unlike Transcatheter aortic valve replacement, SAVR allows:
- Complete annular debridement
- Abscess repair
- Annular enlargement
- Root replacement
- Concomitant multivessel CABG
- Durability advantage in younger patients
Transcatheter aortic valve replacement (TAVR) is preferred in:
- Elderly patients
- High or prohibitive surgical risk
- Frailty or hostile chest[1]
Preoperative management
Patient evaluation
| System | Considerations |
|---|---|
| Neurologic | -Syncope history (critical AS)
-Carotid disease (stroke risk) |
| Cardiovascular | -AVA, mean gradient, velocity (severity)
-LVEF, LVH vs LV dilation (pressure or volume overload) -Diastolic dysfunction (preload sensitivity) -pulmonary HTN (RV risk post bypass) -CAD (concomitant CABG) -Rhythm (atrial fibrillation) |
| Pulmonary | -Restrictive lung physiology (HF/sternotomy)
-COPD (prolonged vent weaning) |
| Gastrointestinal | -Dysphagia, esophageal/GI tract surgeries (TEE) |
| Hematologic | -Anticoagulation use, blood products available |
| Renal | -Baseline Cr, kidney disease (CPB AKI risk) |
| Endocrine | -DM |
| Other | -Endocarditis (longer CPB) |
Labs and studies
Operating room setup
Patient preparation and premedication
Regional and neuraxial techniques
Intraoperative management
Monitoring and access
Induction and airway management
Positioning
Maintenance and surgical considerations
Emergence
Postoperative management
Disposition
Pain management
Potential complications
Procedure variants
| Variant 1 | Variant 2 | |
|---|---|---|
| Unique considerations | ||
| Position | ||
| Surgical time | ||
| EBL | ||
| Postoperative disposition | ||
| Pain management | ||
| Potential complications |
References
- ↑ Otto, Catherine M.; Nishimura, Rick A.; Bonow, Robert O.; Carabello, Blase A.; Erwin, John P.; Gentile, Federico; Jneid, Hani; Krieger, Eric V.; Mack, Michael; McLeod, Christopher; O’Gara, Patrick T. (2021-02-02). "2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines". Circulation. 143 (5). doi:10.1161/CIR.0000000000000923. ISSN 0009-7322.
Top contributors: Zining Chen, Olivia Sutton and Chris Rishel